Search

RotaTeq, orale oplossing

Active substance:
  • HUMAAN ROTAVIRUSVACCIN, Levend verzwakt, reassortant serotype G1 (stam W179-9) 1.1 >= E/ml
  • HUMAAN ROTAVIRUSVACCIN, Levend verzwakt, reassortant serotype G2 (stam SC2-9) 1.4 >= E/ml
  • HUMAAN ROTAVIRUSVACCIN, Levend verzwakt, reassortant serotype G3 (stam W178-8) 1.1 >= E/ml
  • HUMAAN ROTAVIRUSVACCIN, Levend verzwakt, reassortant serotype G4 (stam BrB-9) 1 >= E/ml
  • HUMAAN ROTAVIRUSVACCIN, Levend verzwakt, reassortant serotype P1(8) (stam W179-4) 1.15 >= E/ml
Excipients:
  • DULBECCO'S GEMODIFICEERD EAGLES MEDIUM
  • NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)
  • NATRIUMHYDROXIDE (E 524)
  • POLYSORBAAT 80 (E 433)
  • SACCHAROSE
  • TRINATRIUMCITRAAT 2-WATER (E 331)
  • WATER, GEZUIVERD


Marketing authorisation number: EU/1/06/348
Authorisation date: 27 June 2006
Not available